Europe - EBR:IBAB - BE0003766806 - Common Stock
The current stock price of IBAB.BR is 11.58 EUR. In the past month the price increased by 0.17%. In the past year, price decreased by -13.99%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 26.63 | 194.17B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 58.13 | 143.59B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 56.39 | 139.27B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 36.53 | 130.99B | ||
2M6.DE | MEDTRONIC PLC | 16.87 | 102.37B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 20.01 | 53.72B | ||
BOX.DE | BECTON DICKINSON AND CO | 13.28 | 46.49B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 30.48 | 39.37B | ||
DC4.DE | DEXCOM INC | 44.92 | 25.55B | ||
1DXCM.MI | DEXCOM INC | 45.45 | 25.13B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 16.83 | 23.34B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 16.69 | 23.15B |
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,118 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
ION BEAM APPLICATIONS
Chemin du Cyclotron 3
Louvain-la-Neuve BRABANT-WALLON BE
Employees: 1943
Phone: 3210475811
The current stock price of IBAB.BR is 11.58 EUR. The price decreased by -0.86% in the last trading session.
The exchange symbol of ION BEAM APPLICATIONS is IBAB and it is listed on the Euronext Brussels exchange.
IBAB.BR stock is listed on the Euronext Brussels exchange.
10 analysts have analysed IBAB.BR and the average price target is 15.81 EUR. This implies a price increase of 36.53% is expected in the next year compared to the current price of 11.58. Check the ION BEAM APPLICATIONS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ION BEAM APPLICATIONS (IBAB.BR) has a market capitalization of 350.64M EUR. This makes IBAB.BR a Small Cap stock.
ION BEAM APPLICATIONS (IBAB.BR) currently has 1943 employees.
ION BEAM APPLICATIONS (IBAB.BR) has a support level at 11.39 and a resistance level at 11.76. Check the full technical report for a detailed analysis of IBAB.BR support and resistance levels.
The Revenue of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 16.35% in the next year. Check the estimates tab for more information on the IBAB.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ION BEAM APPLICATIONS (IBAB.BR) has a dividend yield of 1.45%. The yearly dividend amount is currently 0.17. Check the full fundamental report for a detailed analysis of IBAB.BR dividend history, reliability and sustainability.
ION BEAM APPLICATIONS (IBAB.BR) will report earnings on 2025-11-20.
The PE ratio for ION BEAM APPLICATIONS (IBAB.BR) is 20.32. This is based on the reported non-GAAP earnings per share of 0.57 and the current share price of 11.58 EUR. Check the full fundamental report for a full analysis of the valuation metrics for IBAB.BR.
ChartMill assigns a technical rating of 3 / 10 to IBAB.BR. When comparing the yearly performance of all stocks, IBAB.BR is a bad performer in the overall market: 88.43% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR. There are concerns on the financial health of IBAB.BR while its profitability can be described as average.
Over the last trailing twelve months IBAB.BR reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS increased by 110.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.86% | ||
ROA | 1.5% | ||
ROE | 8.34% | ||
Debt/Equity | 0.23 |
10 analysts have analysed IBAB.BR and the average price target is 15.81 EUR. This implies a price increase of 36.53% is expected in the next year compared to the current price of 11.58.
For the next year, analysts expect an EPS growth of 208.45% and a revenue growth 16.35% for IBAB.BR